Orfiril Long (Sodium Valproate)

Sodium Valproate, the active ingredient in Orfiril Long, is an anticonvulsant presented as a oral tablet for systemic use. It is used to treat certain seizure types and is prescribed for patients requiring long‑term seizure control.

GNH USA supplies Orfiril Long as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Orfiril Long is an antiepileptic medication that acts on neuronal excitability in the central nervous system. - Generalised tonic‑clonic seizures: helps reduce the frequency and severity of seizures. - Absence seizures: provides control of brief staring episodes. - Myoclonic seizures: diminishes the occurrence of sudden muscle jerks.

Adverse reactions to sodium valproate may vary in frequency and severity.

Common Side Effects: - Nausea and vomiting - Tremor - Weight gain - Hair loss - Drowsiness - Elevated liver enzymes

Serious or Rare Side Effects: - Severe liver injury - Pancreatitis - Thrombocytopenia - Hyperammonemia - Stevens‑Johnson syndrome - Acute encephalopathy

When using Orfiril Long, clinicians should consider several safety measures. - Pregnancy risk: caution     - Liver function monitoring:   - Blood count   - Concomitant drug   - Avoid alcohol  - Store at ambient : keep  

---